A multicenter, randomized, open-label trial: efficacy of once-daily versus twice-daily double-dose rabeprazole on refractory gastroesophageal reflux disease-related symptoms and quality of life - Mizuki, A; Tatemichi, M; Sakakibara, T (Curr Ther Res Clin Exp, 2016)
et al.